28 June 2024
Latham Advises Intuitive Ventures on Amber Therapeutics’ US$100 Million Series A
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Shing Lo Lead | Latham & Watkins LLP | Partner | corporate | London |
| Jim Morrone | Latham & Watkins LLP | Partner | Not stated | Bay Area |
| Beatrice Leung | Latham & Watkins LLP | Associate | Not stated | Not stated |
Stated terms
- Stated value
- USD 100m (US$100 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Amber Therapeutics (Issuer)
New Enterprise Associates (Investor)
Intuitive Ventures (Investor)
F-Prime Capital (Investor)
Lightstone Ventures (Investor)
Oxford Science Enterprises (Investor)
8VC (Investor)